In Heartburn Heartburn and acid reflux happens when a muscle above your stomach relaxes too much and allows stomach contents and acid to come back up into your esophagus and mouth. EMRAB 10 MG TABLET belongs to a group of medicines called proton pump inhibitors. It reduces the amount of acid your stomach makes and relieves the pain associated with heartburn and acid reflux. You can increase the efficiency of the medicine by making certain lifestyle changes. These include avoiding foods that trigger the symptoms, eating smaller more frequent meals, losing weight if you are overweight. In Gastroesophageal reflux disease (Acid reflux) GERD is a chronic (long-term) condition which is like having heartburn consistently rather than just occasionally. It happens because a muscle above your stomach relaxes too much and allows stomach contents to come back up into your esophagus and mouth. EMRAB 10 MG TABLET belongs to a group of medicines called proton pump inhibitors. It reduces the amount of acid your stomach makes and relieves the pain associated with heartburn and acid reflux. You should take it exactly as it is prescribed for it to be effective. Some simple lifestyle changes can help reduce the symptoms of GERD. Think about what foods trigger heartburn and try to avoid them; eat smaller more frequent meals; try to lose weight if you are overweight and try to find ways to relax. Do not eat within 3-4 hours of going to bed. In Peptic ulcer disease EMRAB 10 MG TABLET belongs to a group of medicines called proton pump inhibitors. It reduces the amount of acid your stomach makes which prevents further damage to the ulcer as it heals naturally. You may be given other medicines along with this medicine depending on what caused the ulcer. You need to keep taking the medicine as it is prescribed for it to be effective, even if the symptoms seem to disappear.
Caution is advised when consuming alcohol with EMRAB 10 MG TABLET. Please consult your doctor.
EMRAB 10 MG TABLET may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
EMRAB 10 MG TABLET is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
It is not known whether EMRAB 10 MG TABLET alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
EMRAB 10 MG TABLET is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of EMRAB 10 MG TABLET may not be needed in these patients. Please consult your doctor.
EMRAB 10 MG TABLET should be used with caution in patients with severe liver disease. Dose adjustment of EMRAB 10 MG TABLET may be needed. Please consult your doctor.
If you miss a dose of EMRAB 10 MG TABLET, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Janssen Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sienna Formulations Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Akumentis Healthcare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zuventus Healthcare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Succor Health Care Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Emcure Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Emcure Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Hetero Drugs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Prisure Medicare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zenvita Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)